₁₇M Zeitz

Summary for 2004 [at-glance overview of M Zeitz work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author M Zeitz. According to available data, in 2004 M Zeitz published at least 17 articles. This work was completed in collaboration with several authors including Scherübl, H and Hoffmann, J C. Many other authors have collaborated with M Zeitz as well. There is no information about the funding or the grants awarded to support this work.

M Zeitz has rank 8 when compared to all other authors using the keyword Gastrointestinal Agents. Analysis of the article abstracts and the titles suggests that M Zeitz professional interests are focused around "necrosis factor alpha", "tumour necrosis factor" and "tnf-alpha antibody therapy". These might also be referred to as "db db", "ht-29 b6" or "crohn disease". Statistical analysis shows that M Zeitz's writing is likely to contains terms "db", "disease", "cells", "mice", "epithelial" and "leptin".

Unfortunately, there is not enough information to establish M Zeitz affiliation. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for M Zeitz]

Do you know M Zeitz who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to M Zeitz]

₁₀₇Zeitz, Martin

Year 2004 Charts [M Zeitz frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of M Zeitz publication and funding history for the range of years]

Emails (8) [email addresses extracted from M Zeitz affiliations]

hidden to prevent spam, click here to reveal

M Zeitz Coauthors (76) [all coauthors with the number of joint publications]

6

3

3

2

2

2

2

2

2

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

₁Gamboni-Robertson, F

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (17) [condensed summary of the M Zeitz affiliations, the leading number and the color conveys importance]

₁Ruhr-Universität Bochum, Medizinische Universitätsklinik.
₁Medizinische Klinik Gastroenterologie, Infektiologie, Pneumologie Klinikum Ernst von Bergmann Potsdam.
₁Medizinische Klinik I, Charitè-Universitary Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin 12200, Germany.
₁Medizinische Klinik I, Gastroenterologie, Rheumatologie und Infektiologie, Charité -- Universitätsmedizin Berlin, Campus Benjamin Franklin.
₁Medizinische Klinik I mit Schwerpunkt Gastroenterologie/Infektiologie/Rheumatologie, Charité, Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin.
₁Medizinische Klinik I mit Schwerpunkt Gastroenterologie/Infektiologie/Rheumatologie, Charité, Universitätsmedizin Berlin.
₁Charité -- Universitätsmedizin Berlin, Campus Benjamin Franklin, Medizinische Klinik I -- Gastroenterologie, Infektiologie und Rheumatologie.
₁Medical Clinic I, Gastroenterology, Infectiology, and Rheumatology, Berlin, Germany.
₁Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Medizinische Klinik (Gastroenterologie, Infektiologie und Rheumatologie).
₁Charite Universitaetsmedizin Berlin, Campus Benjamin Franklin, Medizinische Klinik I, Hindenburgdamm 30, 12200 Berlin, Germany.
₁Medizinische Klinik I/Gastroenterologie, Infektiologie and Rheumatologie, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin.
₁Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, I. Medizinische Klinik - Gastroenterologie/Infektiologie/Rheumatologie, Berlin.
₁Medizinische Klinik I, Charité, Campus Benjamin Franklin, Berlin.
₁Medizinische Klinik I, Gastroenterologie, Infektologie, Rhematologie, Charité, Campus Benjamin Franklin, Berlin.
₁Department of Internal Medicine II, Saarland University, Homburg, Germany.
₁Medizinische Klinik I, Gastroenterologie/Infektiologie/Rheumatologie, Charité- Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
₁Department of Medicine I, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Germany.

Key Opinion Leader In [M Zeitz is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₈Gastrointestinal Agents | ₃₆Colitis, Ulcerative | ₅₁Intestinal Mucosa | ₆₁Crohn Disease | ₈₇Germany | ₄₈₁Risk Factors | ₈₇₄Apoptosis

Keywords (32) [keywords assigned to M Zeitz articles by PubMed, the leading number and the color conveys importance]

₁₅Humans | ₅Risk Factors | ₄Germany | ₄Adult | ₄Male | ₃Gastrointestinal Agents | ₃Crohn Disease | ₃Apoptosis | ₃Intestinal Mucosa | ₃Colitis, Ulcerative | ₃Female | ₂Esophageal Neoplasms | ₂Interleukin-12 | ₂Colorectal Neoplasms | ₂Child | ₂Antineoplastic Combined Chemotherapy Protocols | ₂Evidence-Based Medicine | ₂Cross-Sectional Studies | ₂Gastrinoma | ₂Animals | ₂Cell Transformation, Neoplastic | ₂Randomized Controlled Trials as Topic | ₂Insulinoma | ₂Tumor Necrosis Factor-alpha | ₂Mice | ₂Diagnosis, Differential | ₂Colitis | ₂Disease Progression | ₂Adenocarcinoma | ₂Signal Transduction | ₂Incidence | ₂Prospective Studies

M Zeitz Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; M Zeitz might be a good expert witness on these terms]

₁₄db | ₁₃disease | ₁₃cells | ₁₂mice | ₁₂epithelial | ₁₁leptin | ₁₀therapy | ₁₀cancer | ₉intestinal | ₉treatment | ₉receptor | ₉patients | ₈secretion | ₇colitis | ₇sc | ₇aeromonas | ₇protein | ₇norovirus | ₇results | ₆antibody | ₆ht-29 | ₆diagnosis | ₆inflammation | ₆beta-hemolysin | ₆b6 | ₆active | ₆expression | ₆clinical | ₅apoptosis | ₅wt | ₅resistance | ₅crohn
₇db db | ₆ht-29 b6 | ₅crohn disease | ₅rb cells | ₄strain sb | ₄inflammatory bowel | ₄protein kinase | ₃tnf-alpha antibody | ₃antibody therapy | ₃factor alpha | ₃necrosis factor | ₃tumour necrosis | ₃leptin receptor | ₃aeromonas hydrophila | ₃fusion protein | ₃therapy esophageal | ₃il-12 p40 | ₃bowel disease | ₃intestinal inflammation | ₃db rb | ₃diagnosis therapy | ₃induces active | ₃scid mice | ₃epithelial apoptoses | ₃p40 igg2b | ₃lymphocytes modulates | ₃inflammation mice | ₃understanding molecular | ₃epithelial resistance | ₃cells ht-29 | ₃medical treatment | ₂wt cells
₃necrosis factor alpha | ₃tumour necrosis factor | ₃tnf-alpha antibody therapy | ₃cells ht-29 b6 | ₃db rb cells | ₃db db rb | ₃il-12 p40 igg2b | ₃inflammatory bowel disease | ₃intestinal inflammation mice | ₂interleukin p40-igg2b fusion | ₂protein abrogates cell | ₂disease experimental colitis | ₂ht-29 b6 monolayers | ₂mediated inflammation anti-inflammatory | ₂diagnosis therapy esophageal | ₂induces active chloride | ₂downregulation epithelial apoptosis | ₂long-term care facilities | ₂active crohn disease | ₂aeromonas hydrophila beta-hemolysin | ₂p40-igg2b fusion protein | ₂therapy esophageal carcinoma | ₂factor alpha antibody | ₂epithelial apoptosis barrier | ₂disease tumour necrosis | ₂inflammation anti-inflammatory activity | ₂localized squamous cell | ₂db db mice | ₂gastroenteropancreatic tumors multiple | ₂chloride secretion colon | ₂crohn disease tumour | ₂neuroendocrine gastroenteropancreatic tumors

Reader's Comments (0) [comments posted by readers of M Zeitz profile]